Targeting MYC in cancer therapy: RNA processing offers new opportunities. - Wikidata - awgldk - TriplyDB

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

http://www.wikidata.org/entity/Q36762189

about

Targeting MYC Dependence by Metabolic Inhibitors in Cancer Strategies to Inhibit Myc and Their Clinical Applicability Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.Investigation of 'Head-to-Tail'-Connected Oligoaryl N,O-Ligands as Recognition Motifs for Cancer-Relevant G-Quadruplexes.Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins?Identification of potential genes and miRNAs associated with sepsis based on microarray analysis.Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells.The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism

P2860

Q33608493-872BCB1E-2F1B-4E22-A8C6-AE0E774328A1 Q36303678-451C1B0B-80AD-4380-A8A8-A102C21BEC4F Q37049673-827640DF-E9EE-453F-9D19-F906B176AF87 Q48017617-46E46592-CAC9-45D5-899A-AB30EA4B0E33 Q48047139-C990AC57-04DD-47D3-A8F3-74B4FB1F111E Q52370800-AE475D9A-045E-466C-A4B2-D3BDA372F108 Q54260807-96B9C256-1985-4B6D-AC85-BFD4B528C340 Q55248424-FEBA8B74-08FC-4F1A-9744-63FA2DB50076 Q57491556-E66392E2-F526-4828-97D0-C251CE1992D9

P2860

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

http://www.wikidata.org/entity/Q36762189

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@ast

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@en

type

label

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@ast

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@en

prefLabel

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@ast

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@en

P1433

Q36762189-3AA3BFFC-4390-4450-93FD-FA573BA6A0F6

P1476

Q36762189-35438B45-402C-451B-BA62-E0B99F838700

P2093

Q36762189-7936D074-0F46-43B5-8368-3ABF52F79617

Q36762189-FCDC9E6A-0740-45D1-A699-D76F557A326E

P275

Q36762189-3598A289-D5FB-4132-A127-F35226939E92

P2860

Q36762189-00AC2C16-8150-4E4E-964A-D2B703E3B03E

Q36762189-0165D0ED-08C2-4E1B-86C6-26EE3BC08857

Q36762189-036AFAE6-4294-4DD0-ABFD-07478517E188

Q36762189-078F5571-16BD-4C5D-851A-F93E9EE92885

Q36762189-0A1B5B14-1AA5-433C-B083-7A7F0B4C2689

Q36762189-0C07B88E-42A7-4AD4-BB96-9478E6E40081

Q36762189-0D7507A1-AA99-45BF-819D-7C852E515FA5

Q36762189-0E510E2E-2249-43A1-8F28-295A5D65D963

Q36762189-11F769C3-0831-4805-BC03-E48ED06F70C6

Q36762189-1245230B-F427-4A42-80BA-4C24DBF41C1A

P304

Q36762189-753B651C-2E0E-48C3-BC81-486BC056BAB6

P31

Q36762189-B5772D3D-11D5-44D8-A732-09C8D924CA21

Q36762189-DB687BF9-3785-4BA7-9E05-1B3616F1CA7F

P356

Q36762189-D44C0D89-B65A-413B-96FC-78FDF6F24B42

P407

Q36762189-31C2BC81-43E2-4380-A6F6-4E1CD0D13723

P433

Q36762189-38DA07A9-9D45-488E-910E-86EE06EAD967

P478

Q36762189-2BA0C089-8B4B-4946-B53D-61EF13207A59

P50

Q36762189-2E10FF15-0DA4-45F1-A737-2DEA7B9BCBBA

P5008

Q36762189-980D2465-E271-4F1F-B6DD-AC5EACAB5D3A

P577

Q36762189-7BC816A6-554E-44CF-A547-8F5473919F40

Q36762189-94E0F9B8-FFAA-4613-BF42-0206D4AE5ACF

P5875

Q36762189-97B3282E-775F-469C-993E-CFA7A12EE0FA

P698

Q36762189-A74AEFA0-FFB5-4D0F-B8DF-3A1836AC8608

P921

Q36762189-0D311196-ECEC-467F-B05A-BE310368B39F

Q36762189-0F1507EE-33BB-48A6-90E3-6668B14B7558

Q36762189-3063825E-894D-45E2-B5F3-7A4578AA5028

Q36762189-3C6C6C3D-9A1D-47AE-9B67-F7EE39BC3F15

Q36762189-9C42DE61-71EF-4F58-9F64-EC0E291EA782

Q36762189-9EE8DC03-4DE1-418F-9395-5466AA53C73A

P932

Q36762189-75181AFD-00DF-4F0A-ACC8-55B6FB70A2AA

P356

P1433

P1476

Targeting MYC in cancer therapy: RNA processing offers new opportunities.

@en

P2093

Cheryl M Koh

http://www.w3.org/2001/XMLSchema#string

Ernesto Guccione

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

AU binding proteins recruit the exosome to degrade ARE-containing mRNAs

Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc

Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth

Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine

AREsite: a database for the comprehensive investigation of AU-rich elements

Widespread microRNA repression by Myc contributes to tumorigenesis

MYC and the art of microRNA maintenance

Synthetic lethal screens as a means to understand and treat MYC-driven cancers

MYC activation is a hallmark of cancer initiation and maintenance

P304

266-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIES.201500134

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291136390

http://www.w3.org/2001/XMLSchema#string

P698

26778668

http://www.w3.org/2001/XMLSchema#string

P921

nuclear protein

DNA-binding protein

transcription factor

proto-oncogene proteins

neoplasm proteins

P932

4819695

http://www.w3.org/2001/XMLSchema#string